Cogent Biosciences Announces Annual Meeting of Stockholders
June 02 2022 - 8:00AM
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology
company focused on developing precision therapies for genetically
defined diseases, today announced the Annual Meeting of
Stockholders will take place virtually on June 7, 2022 at 9:00am
ET.
All relevant documents and information relating to the annual
meeting, including the notice and agenda, are available in the
Investors and Media section of Cogent’s website under SEC
Filings/DEF 14A “Proxy”. Shareholders of record who wish to
participate should go to the meeting website at
www.virtualshareholdermeeting.com/COGT2022, enter the 16-digit
control number found on their proxy card or Notice, and follow the
instructions.
About Cogent Biosciences, Inc.Cogent
Biosciences is a biotechnology company focused on developing
precision therapies for genetically defined diseases. The most
advanced clinical program, bezuclastinib, is a selective tyrosine
kinase inhibitor that is designed to potently inhibit the KIT D816V
mutation as well as other mutations in KIT exon 17. KIT D816V is
responsible for driving systemic mastocytosis, a serious disease
caused by unchecked proliferation of mast cells. Exon 17 mutations
are also found in patients with advanced gastrointestinal stromal
tumors (GIST), a type of cancer with strong dependence on oncogenic
KIT signaling. In addition to bezuclastinib, the Cogent Research
Team is developing a portfolio of novel targeted therapies to help
patients fighting serious, genetically driven diseases initially
targeting FGFR2 and ErbB2. Cogent Biosciences is based
in Cambridge, MA and Boulder, CO. Visit our
website for more information at www.cogentbio.com. Follow
Cogent Biosciences on social
media: Twitter and LinkedIn. Information that may be
important to investors will be routinely posted on our website and
Twitter.
Contact:
Christi WaarichSenior Director, Investor
Relations617-830-1653christi.waarich@cogentbio.com
Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From Sep 2023 to Sep 2024